Figure 1From: Increased incidence of autoimmune markers in patients with combined pulmonary fibrosis and emphysema Kaplan Meier survival and spearman’s correlation analysis in patients with CPFE with positive and negative immunologic profile. a. Kaplan-Meier survival curve revealed a marginal statistically significant improved survival (p = 0.052) of patients with CPFE and positive ANA profile (median survival of 51 months, range 12 – 96 months) compared to those with negative immunologic profile (38 months, range 16 – 61 months) b. Spearman’s correlation analysis revealed an almost linear positive association between the number of CD20+ cells/mm2 and median survival of patients with CPFE.Back to article page